XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2

SHAREHOLDERS’ DEFICIT (Tables)

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Schedule of Stock option assumptions

Schedule of Stock option assumptions
		September 30, 2021				December 31, 2020
Dividend rate			0	%			0	%
Risk-free rate			2	%			2	%
Weighted average expected life (years)			9 months				9 months
Expected volatility			0	%			0	%(a)
Share price		$	0.22			$	0.22

(a) The Company considered no volatility as from inception through the date there is very minimal transaction of the Company common stock.

Schedule of warrants issued and outstanding

Schedule of warrants issued and outstanding
		Warrants				Weighted average exercise price				Weighted average remaining contractual life (in years)
Outstanding as of December 31, 2019 (a)			21,000			$	0.0001				1.3
Issued (b)			4,094			$	420				0.9
Exercised			(21,838	)		$	(6.34	)			1
Expired			(1,209	)		$	(420	)			(0.6	)
Outstanding as of December 31, 2020			2,047			$	420				0.6
Issued (b)			2,120			$	420				0.5
Exercised			(238	)		$	(420	)			—
Expired			—				—				—
Outstanding as of September 30, 2021 (b)			3,929			$	420				0.5

There is no intrinsic value for warrants as of September 30, 2021 and December 31, 2020.

(a) Common stock will be issued if those warrants exercise.

(b) Preferred stock series C-1 will be issued if those warrants exercise.

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration